The Journal of Pediatrics
Volume 150, Issue 3 , Pages 268-273, March 2007

The Contribution of the DLG5 113A Variant in Early-Onset Inflammatory Bowel Disease

  • R.K. Russell, MRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
    • Corresponding Author InformationReprint requests: Dr R. K. Russell, MRCPCH, Gastrointestinal Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU.
  • ,
  • H.E. Drummond, BSc

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • E.R. Nimmo, BSc, MSc, PhD

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • N. Anderson, BSc, PhD

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • D.C. Wilson, MD, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • P.M. Gillett, MBChB, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • P. McGrogan, MBChB, MRCP

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • K. Hassan, MBBS, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • L.T. Weaver, MD, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • W.M. Bisset, MD, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • G. Mahdi, FRCPCH

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.
  • ,
  • J. Satsangi, DPhil, FRCP

      Affiliations

    • Gastrointestinal Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom
    • Public Health Sciences, Edinburgh University, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, United Kingdom
    • Department of Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom
    • Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, United Kingdom
    • Department of Child Health, University of Glasgow, Glasgow, United Kingdom
    • Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, United Kingdom.

Received 14 July 2006; received in revised form 4 October 2006; accepted 7 December 2006.

Objective

To assess the contribution of the 113 G→A missense mutation within the discs, large homolog 5 (DLG5) gene in childhood-onset inflammatory bowel disease (IBD) in Scotland.

Study design

Two-hundred and ninety-six children with IBD were studied. Parental DNA was also collected for transmission disequilibrium testing (TDT) analysis. Genotyping was performed by TaqMan®. Genotype-phenotype analysis was also undertaken. Socioeconomic status was assigned using a deprivation category (DepCat) score 1 through 7 (1 = most affluent).

Results

TDT analysis demonstrated a significant association with IBD (P = .045). On unifactorial analysis, 113A carriage was associated with: (1) higher social class (DepCat 1 compared with 2-7, and 1-2 compared with 3-7) (66.7% vs 22.6%, P = .0005, OR 6.84 [1.99-23.55] and 37.2% vs 22.2%, P = .03, OR 2.08 [1.04-4.17], respectively); (2) higher height centile (>75th centile vs <75th centile) (42.9% vs 23.1%, P = .01, OR 2.50 [1.18-5.28]); and (3) male sex in Crohn’s disease (CD) (29.3% vs 16.9%, P = .04, OR 2.04 [1.01-4.11]). Multifactorial analysis demonstrated that higher social class (DepCat 1) was independently associated with carriage of variants of 113A (P = .001, OR=6.92 [2.24-21.33]).

Conclusions

DLG5 113A is associated with increased susceptibility to IBD in Scottish children. The effect may be most marked for those children living in relative affluence.

Abbreviations: BMI, Body mass index, CD, Crohn’s disease, DepCat, Deprivation category, DLG5, Discs, large homolog 5, IBD, Inflammatory bowel disease, UC, Ulcerative colitis, TDT, Transmission disequilibrium testing

 

 The University of Edinburgh Medical Faculty Fellowship funds R.K.R. This study is supported by a Wellcome Trust Programme Grant (072789/Z/03/Z) with additional support from Schering Plough and the GI/Nutrition research fund, Child Life and Health, University of Edinburgh.

PII: S0022-3476(06)01187-5

doi:10.1016/j.jpeds.2006.12.010

The Journal of Pediatrics
Volume 150, Issue 3 , Pages 268-273, March 2007